Evolent Health Stock (NYSE:EVH)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$4.58

52W Range

$2.10 - $12.06

50D Avg

$3.62

200D Avg

$4.76

Market Cap

$539.91M

Avg Vol (3M)

$2.78M

Beta

0.83

Div Yield

-

EVH Company Profile


Evolent Health, Inc., a prominent healthcare firm, operates through its subsidiary, Evolent Health LLC, to furnish clinical and administrative solutions to both healthcare payers and providers across the United States. Its operations are divided into two principal segments: Evolent Health Services and Clinical Solutions. The Evolent Health Services division delivers an integrated platform encompassing both administrative and clinical functions, specifically designed for health plan management and the oversight of population health. This includes essential financial and administrative support, such as managing health plan operations, risk assessment, robust analytics and reporting, and strategic leadership. A cornerstone of this segment is "Identifi," its proprietary technology, which intelligently aggregates and analyzes data, streamlines care workflows, and actively engages patients, all with the aim of achieving patient-centered and cost-effective population health outcomes. Conversely, the Clinical Solutions segment specializes in offering sophisticated care management services for various stakeholders involved in specialty care delivery. These services are crucial for organizations transitioning from traditional fee-for-service models to value-based care, accommodating their unique stage of development and prevailing market dynamics, particularly in the fields of oncology and cardiology. The overarching objective of this segment is a holistic improvement in the total cost of care. Founded in 2011, Evolent Health, Inc. maintains its corporate headquarters in Arlington, Virginia.

Show More

Industry

Medical - Healthcare Information Services

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

4,500

IPO Date

Jun 05, 2015

Website

EVH Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 23
Reportable Segment$1.88B--
Evolent Health Services Segment-$2.55B$1.96B

Fiscal year ends in Dec 25 | Currency in USD

EVH Financial Summary


Dec 25Dec 24Dec 23
Revenue$1.88B$2.55B$1.96B
Operating Income$-2.29B$-40.48M$-71.21M
Net Income$-579.40M$-61.62M$-113.04M
EBITDA$-361.31M$84.85M$-24.79M
Basic EPS$-5.07$-0.81$-1.28
Diluted EPS$-5.07$-0.81$-1.28

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q1 26May 07, 26 | 12:00 AM
Q4 25Feb 25, 26 | 5:00 PM
Q3 25Nov 07, 25 | 5:00 PM

Peer Comparison


TickerCompany
PSNLPersonalis, Inc.
AMNAMN Healthcare Services, Inc.
NUTXNutex Health, Inc.
MGTXMeiraGTx Holdings plc
KURAKura Oncology, Inc.
MYGNMyriad Genetics, Inc.
AVBPArriVent BioPharma, Inc. Common Stock
HSTMHealthStream, Inc.
REPLReplimune Group, Inc.
BFLYButterfly Network, Inc.